欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Coumermycin_4434-05-3_产品详情
4434-05-3
  • names:

    Coumermycin

  • CAS号:

    4434-05-3

    MDL Number:
  • MF(分子式): C55H59N5O20 MW(分子量): 1110.092
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Coumermycin
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[5-[[4-hydroxy-7-[(2R,3R,4S,5R)-3-hydroxy-5-methoxy-6,6-dimethyl-4-(5-methyl-1H-pyrrole-2-carbonyl)oxyoxan-2-yl]oxy-8-methyl-2-oxochromen-3-yl]carbamoyl]-4-methyl-1H-pyrrole-3-carbonyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] 5-methyl-1H-pyrrole-2-carboxylate
英文别名 Coumermycin
CAS号 4434-05-3
Inchi InChI=1S/C55H59N5O20/c1-21-12-16-29(57-21)48(67)77-42-38(63)52(79-54(6,7)44(42)71-10)73-31-18-14-26-36(61)34(50(69)75-40(26)24(31)4)59-46(65)28-20-56-33(23(28)3)47(66)60-35-37(62)27-15-19-32(25(5)41(27)76-51(35)70)74-53-39(64)43(45(72-11)55(8,9)80-53)78-49(68)30-17-13-22(2)58-30/h12-20,38-39,42-45,52-53,56-58,61-64H,1-11H3,(H,59,65)(H,60,66)/t38-,39-,42+,43+,44-,45-,52-,53-/m1/s1
InchiKey WTIJXIZOODAMJT-DHFGXMAYSA-N
分子式 Formula C55H59N5O20
分子量 Molecular Weight 1110.092
溶解度Solubility
性状 Solid powder
储藏条件 Storage conditions Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).
产品说明 Coumermycin(CAS:4434-05-3):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。
IntroductionCoumermycin is an antibacterial agent effective against Staphylococcus aureus and Staphylococcus epidermidis.
Application1
Application2
Application3
警示图
危险性 Warning
危险性警示
安全声明
安全防护
备注
[1]Kincade JM, deHaseth PL. Bacteriophage lambda promoters pL and pR: sequence determinants of in vivo activity and of sensitivity to the DNA gyrase inhibitor, coumermycin. Gene. 1991 Jan 2;97(1):7-12. PubMed PMID: 1847348.
[2]Vanden Broeck A, McEwen AG, Chebaro Y, Potier N, Lamour V. Structural Basis for DNA Gyrase Interaction with Coumermycin A1. J Med Chem. 2019 Apr 25;62(8):4225-4231. doi: 10.1021/acs.jmedchem.8b01928. Epub 2019 Apr 3. PubMed PMID: 30920824.
[3] Xu H, Wang ZX, Schmidt J, Heide L, Li SM. Genetic analysis of the biosynthesis of the pyrrole and carbamoyl moieties of coumermycin A1 and novobiocin. Mol Genet Genomics. 2002 Nov;268(3):387-96. Epub 2002 Oct 11. PubMed PMID: 12436260.
[4] Novotna J, Gust B, Kulik A, Spizek J, Heide L. Five gene products are required for assembly of the central pyrrole moiety of coumermycin A1. J Ind Microbiol Biotechnol. 2013 Aug;40(8):915-25. doi: 10.1007/s10295-013-1266-6. Epub 2013 May 8. PubMed PMID: 23652970.
[5] Cele FN, Kumalo H, Soliman ME. Mechanism of Inhibition of Hsp90 Dimerization by Gyrase B Inhibitor Coumermycin A1 (C-A1) Revealed by Molecular Dynamics Simulations and Thermodynamic Calculations. Cell Biochem Biophys. 2016 Sep;74(3):353-63. doi: 10.1007/s12013-016-0743-8. Epub 2016 Jul 4. PubMed PMID: 27376828.
6: Pacholec M, Tao J, Walsh CT. CouO and NovO: C-methyltransferases for tailoring the aminocoumarin scaffold in coumermycin and novobiocin antibiotic biosynthesis. Biochemistry. 2005 Nov 15;44(45):14969-76. PubMed PMID: 16274243.7: Schmutz E, Steffensky M, Schmidt J, Porzel A, Li SM, Heide L. An unusual amide synthetase (CouL) from the coumermycin A1 biosynthetic gene cluster from Streptomyces rishiriensis DSM 40489. Eur J Biochem. 2003 Nov;270(22):4413-9. PubMed PMID: 14622269.8: Garneau-Tsodikova S, Stapon A, Kahne D, Walsh CT. Installation of the pyrrolyl-2-carboxyl pharmacophore by CouN1 and CouN7 in the late biosynthetic steps of the aminocoumarin antibiotics clorobiocin and coumermycin A1. Biochemistry. 2006 Jul 18;45(28):8568-78. PubMed PMID: 16834331.9: Perronne CM, Malinverni R, Glauser MP. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination. Antimicrob Agents Chemother. 1987 Apr;31(4):539-43. PubMed PMID: 3606060; PubMed Central PMCID: PMC174774.10: Neu HC, Chin NX, Labthavikul P. Antibacterial activity of coumermycin alone and in combination with other antibiotics. Antimicrob Agents Chemother. 1984 Jun;25(6):687-9. PubMed PMID: 6331295; PubMed Central PMCID: PMC185623.1
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻

        怎么做细胞爬片免疫组化染色实验

        细胞爬片免疫组化染色,是通过细胞爬片是让玻片浸在细胞培养基内,细胞在玻片上生长,主要用于组织学,免疫组织化学...

        2020/7/20 22:04:33

        提取病毒RNA的实验方法

        提取病毒RNA方法分别有:异硫氰酸胍的提取病毒RNA方法、TRIzol LS提取法、Trizol法提取法等等...

        2020/7/22 20:29:26

        细胞培养耗材技术领先性

        细胞培养板行业面临的核心痛点是:常规TC处理后表面亲水角随时间衰减,影响长期培养稳定性,BIOFOUNT高分...

        2026/4/28 15:12:51

        细胞培养耗材关键性能

        细胞培养板的水接触角作为表面润湿性的核心指标,直接影响细胞贴壁、增殖、分化及功能表达,其中40°(低接触角/...

        2026/4/28 14:52:44

        chelex 100树脂国产替代之路-BIOFOUNT范德生物

        Chelex 100螯合离子交换树脂对铜、铁和其他重金属?的偏好显著高于对钠、钾等一价阳离子的偏好。它对二价...

        2025/11/4 14:22:46

        9月开学季——助研新学期 范德送好礼

        2025/8/28 15:30:55

        Waxfilm 实验室封口膜:技术与国际市场的双重突破

        在实验室耗材领域,封口膜是保障实验准确性与稳定性的关键产品之一。近年来,Waxfilm?实验室封口膜凭借其卓...

        2025/5/13 13:03:40

        Waxfilm实验室封口膜的5大突破

        Waxfilm实验室封口膜作为生物功能膜领域的国产技术突破和品牌突破,是生物领域中国技术发展的缩影。

        2025/5/6 17:02:07

        各种微流控芯片键合方法的优缺点

        微流控芯片键合:目前主要有激光焊接、热压键合、胶键合、超音波焊接,每种方法都有各自的优缺点。本文主要介绍聚酯...

        2023/7/28 10:43:09

        新一代微流控键合解决方案

        微流控键合解决方案:微流控芯片制造的一个重要环节,也是最容易被忽视的--芯片键合。其中一个重要因素是:微流控...

        2023/7/27 12:44:28

        My title page contents